Cargando…
Managing the Risk of Delayed Breast Cancer Screening Versus COVID-19 Vaccination Associated Axillary Lymphadenopathy
Autor principal: | Garver, Kimberly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association of University Radiologists. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349681/ https://www.ncbi.nlm.nih.gov/pubmed/34400078 http://dx.doi.org/10.1016/j.acra.2021.07.022 |
Ejemplares similares
-
COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram
por: Raj, Sean, et al.
Publicado: (2022) -
COVID-19 and lockdown: Delayed effects on health
por: Andrade, Chittaranjan
Publicado: (2020) -
Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum
por: Musaddaq, Besma, et al.
Publicado: (2022) -
Frequency of screening for breast cancer
por: Blamey, R.W.
Publicado: (1989) -
COVID-19 Vaccination and Subclinical Axillary Lymphadenopathy on Mammogram: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)